One day this company will get some decent coverage:
This is a big deal. FDA approval in Striate quickly followed the Striate comparator study....Remplir should be going to market in the US by 2024....and Striate will already be selling well as Bio HOorizons continues it as its leading biological in its sales thrust....
One day this company will get some decent coverage:This is a big...
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.010(2.70%) |
Mkt cap ! $79.54M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.0¢ | 37.5¢ | $16.63K | 43.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 24480 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 20000 | 1 |
View Market Depth
| Last trade - 15.17pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
38.0¢ |
Change
0.010 ( 1.33 %) |
||||
| Open | High | Low | Volume | ||
| 38.0¢ | 38.0¢ | 37.0¢ | 7580 | ||
| Last updated 15.46pm 24/05/2024 ? | |||||
| OCC (ASX) Chart |